
Neurescue
The First and Only Treatment Approved for Non-Shockable Cardiac Arrest CE Marked (NB 2443)
$7.23M Series A ·
Source: startupintros.com
Funding history ↓Signals
Website registeredAug 11, 2013 (13 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $7.23M | — | startupintros.com |
Timeline
- Website created
Similar Health and bio companies
CCytoHubPre Seed · Mar 2026
VVumedi$140M Series B+ · Nov 2026
NNeurosterix$105M Series B+ · Nov 2026
OOSMUNDA$14.99M Series B+ · Nov 2026
BBoston Medical Sciences$34.69M Series B+ · Nov 2026
AAraceli Biosciences$4.5M Seed · Nov 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/neurescue (get a free API key).